Statin Therapy

A study of more than 6,000 white-collar workers found that psychosocial stressors at work raised men’s risk of coronary heart disease while having an inconclusive impact on women.

Researchers in South Korea showed that statin therapy for treatment-naive patients with already low LDL hospitalized for first-time stroke may reduce risk for all-cause death in the following months.

Researchers found a lower prevalence of statin use for primary and secondary atherosclerotic CVD prevention among nonwhite and female patients, which they said may be partially due to factors such as bias and stereotyping.

Recent data show that more than 6.6 million antibiotics are inappropriately prescribed at dental visits each year, resulting in about $31 million each year in health care costs and out-of-pocket expenses.

Older adults derive greater LDL benefits after initiating statin therapy compared with younger adults, regardless of whether statins are prescribed for primary or secondary prevention or to people with diabetes, researchers reported.

Adults with HIV can lower their risk for serious cardiovascular events like heart attack or stroke by more than one-third if they take a daily statin, a large phase 3 trial found.

Statin use for primary prevention was associated with reduced risk for all-cause and CV death among patients with hypertension and no other CVD or diabetes vs. matched controls not on statin therapy, researchers reported.

Most U.S. adults with coronary artery disease are not meeting guideline-recommended LDL targets, even when prescribed statin therapy, according to an analysis of nationwide survey data.

Researchers observed no increased risk for new-onset diabetes among IMPROVE-IT participants assigned to ezetimibe plus statin therapy vs. statin monotherapy, according to a research letter.

Increasing the percentage of people with diabetes who are diagnosed, improving glucose and lipid levels and expanding access to care are key goals detailed in the WHO Global Diabetes Compact.